The past 2 years have seen progress in our understanding of the proces
s of premature ovarian failure with identification of molecular causes
and clarification of the autoimmune targets within the ovary, With th
e knowledge that most women with premature ovarian failure have ovaria
n follicles on ultrasonography, we eagerly await the next therapeutic
landmark - the application of the preservation or in-vitro maturation
of ova.